v3.25.2
Investments
6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Investments

6. Investments

Available-for-sale investments consisted of the following as of June 30, 2025 and December 31, 2024 (in thousands):

 

 

 

June 30, 2025

 

 

 

Amortized Cost

 

 

Unrealized Gain

 

 

Unrealized Loss

 

 

Estimated Fair Value

 

Short-term marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

1,467

 

 

$

 

 

$

(2

)

 

$

1,465

 

U.S. government treasury securities

 

 

128,371

 

 

 

79

 

 

 

(54

)

 

 

128,396

 

Corporate bonds

 

 

24,834

 

 

 

17

 

 

 

(2

)

 

 

24,849

 

Total short-term marketable securities

 

$

154,672

 

 

$

96

 

 

$

(58

)

 

$

154,710

 

Long-term marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government treasury securities

 

$

21,038

 

 

$

29

 

 

$

(2

)

 

$

21,065

 

Corporate bonds

 

 

3,027

 

 

 

8

 

 

 

 

 

 

3,035

 

Total long-term marketable securities

 

$

24,065

 

 

$

37

 

 

$

(2

)

 

$

24,100

 

 

 

 

December 31, 2024

 

 

 

Amortized Cost

 

 

Unrealized Gain

 

 

Unrealized Loss

 

 

Estimated Fair Value

 

Short-term marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

2,476

 

 

$

3

 

 

$

 

 

$

2,479

 

U.S. government treasury securities

 

 

153,353

 

 

 

211

 

 

 

(43

)

 

 

153,521

 

Corporate bonds

 

 

18,357

 

 

 

19

 

 

 

(2

)

 

 

18,374

 

Total short-term marketable securities

 

$

174,186

 

 

$

233

 

 

$

(45

)

 

$

174,374

 

Long-term marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government treasury securities

 

$

33,682

 

 

$

27

 

 

$

(49

)

 

$

33,660

 

Total long-term marketable securities

 

$

33,682

 

 

$

27

 

 

$

(49

)

 

$

33,660

 

 

All the U.S. government treasury securities, corporate bonds and commercial paper designated as short-term marketable securities have an effective maturity date that is equal to or less than one year from the respective condensed consolidated balance sheet date. Those that are designated as long-term marketable securities have an effective maturity date that is more than one year from the respective condensed consolidated balance sheet date.

Accrued interest receivable is excluded from the amortized cost and estimated fair value of our marketable securities. Accrued interest receivable of $1.3 million was presented separately within the prepaid expenses and other current assets balance on the unaudited condensed consolidated balance sheet as of June 30, 2025 and on the condensed consolidated balance sheet as of December 31, 2024.

 

The following table presents the gross unrealized holding losses and fair values for investments in an unrealized loss position, and the length of time individual securities have been in a continuous loss position, as of June 30, 2025 (in thousands):

 

 

 

Less Than 12 Months

 

 

12 Months Or Greater

 

 

 

Fair Value

 

 

Unrealized Loss

 

 

Fair Value

 

 

Unrealized Loss

 

Commercial paper

 

$

1,465

 

 

$

(2

)

 

$

 

 

$

 

U.S. government treasury securities

 

 

73,611

 

 

 

(56

)

 

 

 

 

 

 

Corporate bonds

 

 

5,771

 

 

 

(2

)

 

 

 

 

 

 

Total available-for-sale securities

 

$

80,847

 

 

$

(60

)

 

$

 

 

$

 

 

We periodically review our available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security ratings or sector credit ratings and other relevant market data.

As of June 30, 2025, we did not intend, nor were we more likely than not to be required, to sell our available-for-sale investments before the recovery of their amortized cost basis, which may be maturity. Based on our assessment, we concluded all impairment as of June 30, 2025 to be due to factors other than credit loss, such as changes in interest rates. A credit allowance was not recognized and the impairment of our available-for-sale securities was recorded in other comprehensive loss.